Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous mesenchymal stromal stem cell application for olfactory recovery
RBR-9knf63vPhase 1Not yet recruiting
- Sponsor
- Universidade Estadual de Londrina
- Start
- Dec 2026
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of autologous bone-marrow mesenchymal stem cells in Olfactory disorder, anosmia and Hyposmia, sponsored by Universidade Estadual de Londrina. Primary endpoint: Safety and tolerability. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
autologous bone-marrow mesenchymal stem cells
03
Conditions
Olfactory disorderanosmiaHyposmia
Beyond the preview
Go deeper on RBR-9knf63v.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9knf63v.